compounded semaglutide 503b pharmacy US FDA proposes curbs on mass compounding of Novo, Lilly's weight-loss drugs Compounded Semaglutide Cost Guide 2026:

These drugs initially came to market for diabetes and we have since added obesity, sleep apnea and fatty liver to the list of indications and we expect many more formally recognized indications to follow

GLP-1 drugs, short for glucagon-like peptide-1 receptor agonists, are designed to address both diabetes and obesity

f , Change in body weight

As a result, many women experience: Acne or breakouts Melasma (dark patches on the face) Dry, itchy, or sensitive skin Stretch marks Darkening of nipples, underarms, and inner thighs These changes are normal and usually temporary, but proper care can help manage them safely